Search Results - "Expert review of hematology"

D-dimer level in COVID-19 infection: a systematic review by Rostami, Mehrdad, Mansouritorghabeh, Hassan

“…COVID-19 disease has spread worldwide from December 2019 to the present day; the early stage of this disease can be associated with high D-dimer, prolonged PT,…”
Get more information

Mitochondria and Iron: current questions by Paul, Bibbin T, Manz, David H, Torti, Frank M, Torti, Suzy V

“…Mitochondria are cellular organelles that perform numerous bioenergetic, biosynthetic, and regulatory functions and play a central role in iron metabolism…”
Get more information

High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review by Warkentin, Theodore E

“…: Heparin-induced thrombocytopenia (HIT) is known for its strong association with thrombosis and distinct pathogenesis involving anti-PF4/polyanion antibodies…”
Get more information

Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms by Jiang, Manli, Bennani, N Nora, Feldman, Andrew L

“…Lymphomas are classified based on the normal counterpart, or cell of origin, from which they arise. Because lymphocytes have physiologic immune functions that…”
Get more information

An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura by Joly, Bérangère S, Coppo, Paul, Veyradier, Agnès

“…: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia,…”
Get more information

Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy by Acharya, Utkarsh H, Dhawale, Tejaswini, Yun, Seongseok, Jacobson, Caron A, Chavez, Julio C, Ramos, Jorge D, Appelbaum, Jacob, Maloney, David G

“…Chimeric antigen receptor (CAR) T cell immunotherapy has demonstrated remarkable anti-tumor activity in B-cell malignancies and is under investigation in other…”
Get more information

Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences by Allali, Slimane, Brousse, Valentine, Sacri, Anne-Sylvia, Chalumeau, Martin, de Montalembert, Mariane

“…Anemia in children is a major public health problem throughout the world. It is often multifactorial, iron deficiency being the most frequent etiology…”
Get more information

Postpartum haemorrhage: prevention and treatment by Sentilhes, Loïc, Merlot, Benjamin, Madar, Hugo, Sztark, François, Brun, Stéphanie, Deneux-Tharaux, Catherine

“…Postpartum hemorrhage (PPH) is one of the leading causes of maternal death and severe maternal morbidity worldwide and strategies to prevent and treat PPH vary…”
Get more information

Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia by Al-Samkari, Hanny, Soff, Gerald A

“…: Chemotherapy-induced thrombocytop enia (CIT) is a common complication of cancer treatment causing chemotherapy delays, dose reductions, and treatment…”
Get more information

Thrombophilia, risk factors and prevention by Campello, Elena, Spiezia, Luca, Adamo, Angelo, Simioni, Paolo

“…Fifty-three years after the first description of an inherited prothrombotic condition (antithrombin deficiency), our knowledge on hereditary and acquired…”
Get more information

COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis by Alharbi, Mohammed Ghannam, Alanazi, Nouf, Yousef, Aroob, Alanazi, Nora, Alotaibi, Bader, Aljurf, Mahmoud, El Fakih, Riad

“…Immune thrombocytopenia, also known as immune thrombocytopenic purpura (ITP), has emerged as a significant COVID-19-associated complication. This study…”
Get more information

Impact and management of iron deficiency and iron deficiency anemia in women's health by Mirza, Fadi G, Abdul-Kadir, Rezan, Breymann, Christian, Fraser, Ian S, Taher, Ali

“…Iron deficiency and iron deficiency anemia are highly prevalent among women throughout their lives. Some females are particularly vulnerable to iron…”
Get more information

Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis by Shah, Nirmish, Lipato, Thokozeni, Alvarez, Ofelia, Delea, Thomas, Lonshteyn, Alexander, Weycker, Derek, Nguyen, Andy, Beaubrun, Anne, Agodoa, Irene

“…Sickle cell disease (SCD) is a genetic disease that impacts patients' quality of life, healthcare costs, and life expectancy. Elevated sickle hemoglobin (HbS),…”
Get more information

Neonatal management and outcome in alloimmune hemolytic disease by Ree, Isabelle M C, Smits-Wintjens, Vivianne E H J, van der Bom, Johanna G, van Klink, Jeanine M M, Oepkes, Dick, Lopriore, Enrico

“…Hemolytic disease of the fetus and newborn (HDFN) occurs when fetal and neonatal erythroid cells are destroyed by maternal erythrocyte alloantibodies, it leads…”
Get more information

Lived experience experts: a name created by us for us by Vázquez, Esmeralda, Kim, Michelle, Santaella, Maria E

“…Plain Language SummaryPeople affected by a medical disorder, usually called patients, develop a very special expertise by living with it every day. They know,…”
Get more information

Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures by Barcellini, Wilma, Giannotta, Juri, Fattizzo, Bruno

“…Autoimmune hemolytic anemia (AIHA) is due to autoantibodies against erythrocytes that may arise either because of primary tolerance breakage or along with…”
Get more information

Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia? by Lampson, Benjamin L, Brown, Jennifer R

“…Ibrutinib is the first BTK inhibitor to show efficacy in chronic lymphocytic leukemia (CLL) and is also the first BTK inhibitor to which patients have…”
Get more information

Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update by Kuldanek, Susan A, Kelher, Marguerite, Silliman, Christopher C

“…: Despite mitigation strategies that include the exclusion of females from plasma donation or the exclusion of females with a history of pregnancy or known…”
Get more information

Why factor XI deficiency is a clinical concern by Wheeler, Allison P, Gailani, David

“…Inherited fXI deficiency has been an enigma since its discovery in 1953. The variable and relatively mild symptoms in patients with even the most severe form…”
Get more information

A review of FDA-approved acute myeloid leukemia therapies beyond '7 + 3' by Bazinet, Alexandre, Assouline, Sarit

“…: The standard anthracycline and cytarabine-based chemotherapy for acute myeloid leukemia (AML) has changed relatively little since the 1970s and produces…”
Get more information